Article from The Center for Biosimilars of the covering the Biosimilars Canada Board Chair and Vice-Chair announcement, and key developments in the Canadian biosimilars landscape.
Biosimilars Canada has compiled a list of news stories from Canada and abroad about biosimilars that may be of interest to readers. These links to third-party websites are provided for informational purposes only, and do represent an endorsement from our organization. Biosimilars Canada’s statements and news releases are available here.
Anar Dossa, Director of Pharmacy Services at Pacific Blue Cross, shares the private insurer’s success and savings with biosimilar switching and future plans in this interview with the Not So Different podcast.
This Pacific Blue Cross op-ed in Business in Vancouver notes that the savings from biosimilars are a welcome influx of resources as COVID-19 continues to exhaust the B.C.’s healthcare system, enabling the Ministry to reallocate money towards other pressing health needs.
A 20Sense Report interview with Dr. Alan Low on the impact of BC’s biosimilar policies.
Biosimilars have made great strides in Canada but have a lot further to go, as explored in this 20Sense Report article.
Benefits Canada report on the Face to Face Drug Plan Management Forum held on December 9, 2020.